Spironolactone for Acne: What to Expect Week by Week in the First Month
The first month of spironolactone is mainly about establishing a routine, checking tolerability and tracking your skin's starting point. Some people notice less oiliness or fewer breakouts within weeks, but meaningful acne improvement commonly takes several months. A Mayo Clinic series of 395 adult patients found a median of three months to initial response and five months to maximum response. [1,2]
Spironolactone reduces the effect of androgens on oil glands. The American Academy of Dermatology includes it among recommended systemic options for acne. Your starting dose, other acne treatments and follow-up plan should work together. [3]
A practical week-by-week plan
This is a tracking schedule you can use with your prescription. It helps you compare progress consistently without expecting a specific biological milestone on each calendar day.
| Week | Main focus | What to record |
|---|---|---|
| 1 | Establish the prescribed dosing routine | Starting dose, baseline photos, current breakouts and any dizziness or change in urination |
| 2 | Check whether the routine is manageable | Missed doses, symptoms that interfere with daily activity and changes in other medicines or skin products |
| 3 | Compare like with like | New inflamed spots, discomfort and photos taken in the same lighting; menstrual-cycle timing if relevant |
| 4 | Prepare for the first follow-up | Your dose, tolerability, photos, questions and any planned laboratory results |
Week 1: make the routine easy to follow
Use the dose on your prescription and choose a consistent time that you can remember. Spironolactone has a diuretic effect, so increased urination can be more noticeable than a change in acne at the beginning. Dizziness, breast tenderness or menstrual changes are other symptoms to record. [1,4]
Take baseline photographs before relying on memory to judge progress. Keep the angle, lighting and distance similar in later photos. Record the rest of your skin routine, especially prescription topicals, so that your dermatologist can interpret both improvement and irritation.
Week 2: review tolerability
Assess whether symptoms are improving, continuing or interfering with your day. Tell the prescribing team about persistent dizziness, troublesome menstrual changes or breast discomfort. They can decide whether timing, dose or the treatment plan needs to change. [1,4]
Continue the agreed acne routine. A new cleanser, acid or retinoid added midway through treatment can make it harder to tell which product is responsible for irritation. Bring those changes to follow-up rather than attributing every new symptom to spironolactone.
Week 3: look for a trend
A few better days can be encouraging, while a menstrual-cycle flare can temporarily change the picture. Compare photographs and counts of new inflamed spots over time. Use those observations at follow-up to review how the broader treatment plan is working.
Week 4: review the plan before changing the dose
An early visit often addresses tolerability and dose planning. AAD patient guidance describes follow-up every four to six weeks when starting spironolactone. [1]
In the SAFA randomized trial, participants took 50 mg daily until week six, then increased to 100 mg daily through week 24. That is one studied schedule. A week-four dose increase is not an automatic step for every patient; use the schedule agreed with your prescriber. [5]
When should the acne itself improve?
The SAFA trial randomized 410 adult women to spironolactone or placebo while allowing continued topical treatment. Acne-specific quality-of-life results favored spironolactone at 12 weeks, with a larger difference at 24 weeks. At week 24, 82% of spironolactone participants reported improvement, compared with 63% receiving placebo. [5]
The Mayo Clinic findings also put the first month in perspective: the median initial response occurred at three months. That was an observational study of clinical care, with a median daily dose of 100 mg. It supports allowing time to assess response while keeping follow-up in place. [2]
For longer-term comparison, the FASCE trial randomized 133 women with moderate acne to regimens using spironolactone or doxycycline, both initially combined with benzoyl peroxide. Treatment success at six months favored the spironolactone regimen. The doxycycline course lasted three months, followed by placebo for three months, so the result compares those specific treatment plans. [6]
Do you need potassium or kidney tests in the first month?
Testing depends on the person. The 2024 AAD guideline says routine potassium monitoring is unnecessary in healthy acne patients, while recommending consideration of testing with older age, relevant medical conditions or interacting medicines. Kidney disease, hypertension and diabetes can change that assessment. [3]
The Aldactone prescribing information contains broader potassium-monitoring instructions for its approved uses, including testing within a week of starting or increasing treatment. Your prescriber should explain how your health and medication list determine the schedule being used for acne. [4]
Bring a list of prescriptions, supplements and salt substitutes. Avoid potassium supplements and potassium-based salt substitutes unless your clinician has approved them. Medicines such as ACE inhibitors, ARBs and NSAIDs can also affect potassium or kidney function with spironolactone. [4]
Symptoms and pregnancy planning
Seek prompt medical advice for fainting or severe dizziness, marked weakness or cramps, much less urine, or a rash with fever. These symptoms need assessment rather than waiting for the routine acne visit. Spironolactone should be avoided during pregnancy; discuss pregnancy plans and contraception with your prescriber before treatment, and stop treatment and contact them promptly if pregnancy occurs. [4]
Common questions
Does no improvement after four weeks mean it has failed?
Four weeks is early compared with the three- to six-month assessment periods in the studies above. Review tolerability and the treatment plan at follow-up, then assess acne over the agreed interval. [2,5]
Is an early breakout a sign that spironolactone is working?
Use the overall trend in acne and symptoms to assess response. An early breakout does not establish effectiveness. Record it and discuss persistent worsening at follow-up.
Can I keep using my topical acne medicine?
Follow the combination plan prescribed for you. Continued topical treatment was allowed in SAFA, and the AAD supports treatment plans using complementary mechanisms. [3,5]
References
- American Academy of Dermatology. Stubborn acne? Hormonal therapy may help.
- Roberts EE et al. Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007-2017. Journal of the European Academy of Dermatology and Venereology, 2020.
- Reynolds RV et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 2024.
- Pfizer. Aldactone (spironolactone): U.S. prescribing information.
- Santer M et al. Effectiveness of spironolactone for women with acne vulgaris: SAFA randomized trial. BMJ, 2023.
- Dréno B et al. Efficacy of spironolactone compared with doxycycline in moderate acne in adult females: FASCE study. Acta Dermato-Venereologica, 2024.